KOREA PHARM & BIO is the most influential exhibition in the Korean pharmaceutical & Bio-pharma market, and more than 150 exhibitors are participating this event to introduce their new products. Each year, over 60,000 users, distributors and buyers visit the exhibition to explore and communicate new technologies.
KOREA PHARM & BIO2020 will cover pharmaceuticals, ingredients / health ingredients / biopharmaceuticals / contract services & outsourcing / analytical, consulting, service / smart healthcare / pharmaceutical • bio new technology, and much more. The exhibition is distinguished by its diversity of products and services and the diverse internationality of the exhibitors and visitors.
KOREA PHARM & BIO 2020 is the ideal business platform for pharmaceutical & bio-pharma manufacturers and suppliers to upgrade technological capabilities, enhance competitiveness in the market and stay up to date on the industry trends. It is also a prominent gateway for industry leaders to learn from and network with professionals from around the world, exchange knowledge and know-how, as well as discuss potential business partnerships.
KOREA PHARM & BIO 2019 – A flash back to a successful year
KOREA PHARM & BIO 2019 recorded an impressive attendance of 38,130 trade visitors from 48 countries and regions. It was not just a product showcase, the everyday trade event was packed with concurrent seminars and conferences, gathering industry experts & delegates where everyone was able to learn, network and get immersed in industry insights and topical debates, as well as facilitated business and information exchange.
Highlight of KOREA PHARM &BIO 2020 : AI in Drug Discovery Conference
Ai in Drug Discovery conference will be held during the show with the speakers who are industry leaders pharmaceutical and biotechnology. With the topics, The applications of AI in Drug Discovery (Speaker: twoXAR), Large-scale Mining of Drug-induced Transcriptome for Next Generation Drug Discovery (Speaker: Ewha Womans University / KaiPharm), Multi-OMICS Network AI for Drug Discovery (Speaker: MEDIRITA Inc.), Molecule Design and Quantum Computing (Speaker: Pharos iBT) and The Role of AI platform in Anticancer Drug Discovery (Speaker: DGMIF NDDC), this conference will help you to give the useful information.
KOREA PHARM & BIO 2020 will return from 14 to 17 April 2020 at Korea Intl Exhibition & Convention Center (KINTEX).
For more information, please visit our website, www.koreapharm.org
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Chicago agricultural futures prices on the 6th
L'Oreal Group officially acquires Clarins' perfume brands Mugler and Azzaro
Jingming as chief technology officer of continental China
BASF and Toray sign supply agreement for automobile industry
Technip FMC acquires sol based epichlorohydrin Technology
Ethylene glycol's price continues to bottom in the short term